For: | Pan ZG, Xiao C, Su DX. No association of G-protein beta polypeptide 3 polymorphism with irritable bowel syndrome: Evidence from a meta-analysis. World J Gastroenterol 2014; 20(20): 6345-6352 [PMID: 24876757 DOI: 10.3748/wjg.v20.i20.6345] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i20/6345.htm |
Number | Citing Articles |
1 |
Dongbo Jiang, Dong Huang, Weiming Cai, Ting Li, Yan Wang, Huayan Chen, Tangming Guan, Xiaoli Ma. G protein beta 3(GNβ3) C825T polymorphism and irritable bowel syndrome susceptibility: an updated meta-analysis based on eleven case-control studies. Oncotarget 2018; 9(2): 2770 doi: 10.18632/oncotarget.23449
|
2 |
E. A. Trush, A. E. Karchevskaya, R. V. Maslennikov, E. A. Poluektova, O. S. Shifrin, V. T. Ivashkin. Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(3): 62 doi: 10.22416/1382-4376-2024-34-3-62-77
|
3 |
Shiwei Zhu, Ben Wang, Qiong Jia, Liping Duan. Candidate single nucleotide polymorphisms of irritable bowel syndrome: a systemic review and meta-analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1084-z
|
4 |
Qi-Yun Xiao, Xiu-Cai Fang, Xiao-Qing Li, Gui-Jun Fei. Ethnic differences in genetic polymorphism associated with irritable bowel syndrome. World Journal of Gastroenterology 2020; 26(17): 2049-2063 doi: 10.3748/wjg.v26.i17.2049
|
5 |
Farisah Sulaimi, Timothy Sheng Khai Ong, Ansel Shao Pin Tang, Jingxuan Quek, Renish M. Pillay, Damien Tianle Low, Charisse Kai Ling Lee, Kewin Tien Ho Siah, Qin Xiang Ng. Risk factors for developing irritable bowel syndrome: systematic umbrella review of reviews. BMC Medicine 2025; 23(1) doi: 10.1186/s12916-025-03930-5
|